Sort   by:  
 Page size 
UnknownPeriventricular hyperintensities are associated with elevated cerebral amyloid.
Not available
S-EPMC4753726 | biostudies-literature
UnknownPolygenic risk of Alzheimer disease is associated with early- and late-life processes.
Not available
S-EPMC4970660 | biostudies-literature
UnknownHNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder.
Not available
S-EPMC10432175 | biostudies-literature
UnknownGlucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment.
Not available
S-EPMC9616982 | biostudies-literature
UnknownPattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty.
Not available
S-EPMC5656688 | biostudies-literature
UnknownPrevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease.
Not available
S-EPMC10391361 | biostudies-literature
UnknownLongitudinal changes in peripapillary atrophy in the ocular hypertension treatment study: a case-control assessment.
Not available
S-EPMC4682350 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownAspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
Sort   by:  
 Page size